Shopping Cart 0
Cart Subtotal
AED 0

Belgium and Netherlands Advance Wound Care Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 9175

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 11744

Details

In this region, Belgium advanced wound care market is projected to reach USD 28.0 million by 2024 from USD 22.6 million in 2016, at a CAGR of 2.8% in the forecast period 2017 to 2024. Netherlands advanced wound care market is projected to reach USD 167.9 million by 2024 from USD 135.4 million in 2016, at a CAGR of 2.8% in the forecast period 2017 to 2024.

Some of the major players operating in this market are

Acelity L.P. INC,

Smith and Nephew,

Molnlycke, Convatec INC.,

3M,

Baxter,

Coloplast,

Ethicon INC.,

Paul Hartmann Limited

The Belgium and Netherlands advance wound care market is segmented on the basis of type, wound type, end-user, distribution channel, and geography. The Belgium and Netherlands advance wound care market is segmented into three types, such as dressing, therapy devices and biologics

Dressing is further segmented into foam dressings, hydrogels, film dressings, alginates, wound contact layer, and super absorbent dressing. Also, biologics market is further segmented into synthetic skin grafts, growth factors, allografts, and xenografts.

The therapy devices are further segmented into negative pressure wound therapy, pressure relief devices (PRD), wound debridement devices, hyperbaric oxygen chambers, and physical therapies.

The growth factors are further divided into platelet-derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), Talactoferrin ALFA, thrombin peptide (TP508), and keratinocyte growth factor (KGF).

The negative pressure wound therapy (NPWT) is further classified into standalone NPWT devices, portable NPWT devices, and disposable NPWT devices. The pressure relief devices (PRD) are further classified into mattress and bed.

The hyperbaric oxygen chambers are further classified into monoplace, multiplace, and topical. The wound debridement devices are further classified into hydrosurgical, ultrasound, mechanical, and others. The physical therapies are further classified into laser therapy, electrical stimulation, external shock wave therapies (ESWT), and saline mist therapy.

On the basis of wound type, the Belgium and Netherlands advance wound care market is segmented into surgical wound, diabetic ulcers, burns, pressure ulcers, venous ulcers and others.

On the basis of end users, the Belgium and Netherlands advance wound care marketis segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics and community healthcare.

On the basis of distribution channel, the Belgium and Netherlands advance wound care marketis segmented into direct tenders and retailers.

READ MORE

Table Of Content

Scope

Table Of Contents

1. Introduction

1.1 Overview Of The Belgium And Netherlands Advanced Wound Care Market

1.2 Currency And Pricing

1.3 Limitation

1.4 Markets Covered

2 Market Segmentation

2.1 Key Takeaways

2.2 Arriving At The Belgium And Netherlands Advanced Wound Care Market

2.2.1 Market Crackdown Approach

2.2.2 Company Revenue And Market Share Analysis

2.2.3 Data Triangulation

2.2.4 Key Data Points From Primary Sources

2.2.5 Key Data Points From Secondary Sources

2.2.6 Porter'S Five Forces Matrix

2.2.7 Pest Analysis

2.2.8 Epidemiology Forecasting Models

2.3 Belgium And Netherlands Advanced Wound Care Market:Research Snapshot

2.4 Assumptions

3 Market Overview

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

4 Executive Summary

5 Premium Insights

6 Belgium And Netherlands Advanced Wound Care Market, By Type

6.1 Overview

6.2 Dressings

6.3 Biologics

6.4 Therapy Devices

7 Belgium And Netherlands Advanced Wound Care Market, By Wound Type

7.1 Overview

7.2 Surgical Wounds

7.3 Diabetic Ulcers

7.4 Pressure Ulcers

7.5 Venous Ulcers

7.6 Burns

7.7 Other Traumatic Wounds

8 Belgium And Netherlands Advanced Wound Care Market, By End User

8.1 Overview

8.2 Hospitals

8.3 Wound Care Centers

8.4 Ambulatory Centers

8.5 Clinics

8.6 Community Healthcare

8.7 Home Healthcare

9 Belgium And Netherlands Advanced Wound Care Market, By Istribution Channel

9.1 Overview

9.2 Direct Tenders Public

9.3 Retail Private

10 Belgium And Netherlands Advanced Wound Care Market, By Country

10.1 Countrywise Belgium And Netherlands Advanced Wound Care Market, (All Segmentation Provided Above Is Represented In This Chapter By Country)

10.1.1 Belgium

10.1.2 Netherlands

10.2 Key Primary Insights: By Major Countries

11 Belgium Advanced Wound Care Market: Competitive Landscape

11.1. Belgium Advanced Wound Care Market: Company Share Analysis

11.2. Mergers & Acquisitions

11.3. New Product Development & Approvals

11.4. Expansions

11.5. Regulatory Changes

11.6. Partnership And Other Strategic Developments

12 Netherlands Advanced Wound Care Market: Competitive Landscape

12.1. Netherlands Advanced Wound Care Market: Company Share Analysis

12.2. Mergers & Acquisitions

12.3. New Product Development & Approvals

12.4. Expansions

12.5. Regulatory Changes

12.6. Partnership And Other Strategic Developments

13 Belgium And Netherlands Advanced Wound Care Market, Company Profiles

13.1 3M

13.1.1 Company Overview

13.1.2 Financial Analysis

13.1.3 Product Matrix

13.1.4 Recent Developments

13.1.5 Databridge Analysis

13.2 Smith And Nephew

13.2.1 Company Overview

13.2.2 Financial Analysis

13.2.3 Product Matrix

13.2.4 Recent Developments

13.2.5 Databridge Analysis

13.3 Medtronic

13.3.1 Company Overview

13.3.2 Financial Analysis

13.3.3 Product Matrix

13.3.4 Recent Developments

13.3.5 Databridge Analysis

13.4 Molnlycke Healthcare Ab

13.4.1 Company Overview

13.4.2 Financial Analysis

13.4.3 Product Matrix

13.4.4 Recent Developments

13.4.5 Databridge Analysis

13.5 Convatec Inc

13.5.1 Company Overview

13.5.2 Financial Analysis

13.5.3 Product Matrix

13.5.4 Recent Developments

13.5.5 Databridge Analysis

13.6 Baxter

13.6.1 Company Overview

13.6.2 Financial Analysis

13.6.3 Product Matrix

13.6.4 Recent Developments

13.6.5 Databridge Analysis

13.7 Coloplast

13.7.1 Company Overview

13.7.2 Financial Analysis

13.7.3 Product Matrix

13.7.4 Recent Developments

13.7.5 Databridge Analysis

13.8 Ethicon. Inc

13.8.1 Company Overview

13.8.2 Financial Analysis

13.8.3 Product Matrix

13.8.4 Recent Developments

13.8.5 Databridge Analysis

13.9 Integra Life Sciences Corporation

13.9.1 Company Overview

13.9.2 Financial Analysis

13.9.3 Product Matrix

13.9.4 Recent Developments

13.9.5 Databridge Analysis

13.10 Hollister Inc

13.10.1 Company Overview

13.10.2 Financial Analysis

13.10.3 Product Matrix

13.10.4 Recent Developments

13.10.5 Databridge Analysis

13.11 B. Braun Melsungen Ag

13.11.1 Company Overview

13.11.2 Financial Analysis

13.11.3 Product Matrix

13.11.4 Recent Developments

13.11.5 Databridge Analysis

13.12 Medline Industries

13.12.1 Company Overview

13.12.2 Financial Analysis

13.12.3 Product Matrix

13.12.4 Recent Developments

13.12.5 Databridge Analysis

13.13 Mimedx Group

13.13.1 Company Overview

13.13.2 Financial Analysis

13.13.3 Product Matrix

13.13.4 Recent Developments

13.13.5 Databridge Analysis

13.14 Organo Genesis Inc

13.14.1 Company Overview

13.14.2 Financial Analysis

13.14.3 Product Matrix

13.14.4 Recent Developments

13.14.5 Databridge Analysis

13.15 Talley Group Limited

13.15.1 Company Overview

13.15.2 Financial Analysis

13.15.3 Product Matrix

13.15.4 Recent Developments

13.15.5 Databridge Analysis

13.16 Bsn Medical

13.16.1 Company Overview

13.16.2 Financial Analysis

13.16.3 Product Matrix

13.16.4 Recent Developments

13.16.5 Databridge Analysis

13.17 Devon Medical Products

13.17.1 Company Overview

13.17.2 Financial Analysis

13.17.3 Product Matrix

13.17.4 Recent Developments

13.17.5 Databridge Analysis

13.18 Human Biosciences Inc

13.18.1 Company Overview

13.18.2 Financial Analysis

13.18.3 Product Matrix

13.18.4 Recent Developments

13.18.5 Databridge Analysis

13.19 Advancis Medical

13.19.1 Company Overview

13.19.2 Financial Analysis

13.19.3 Product Matrix

13.19.4 Recent Developments

13.19.5 Databridge Analysis

13.20 Cardinal Health

13.20.1 Company Overview

13.20.2 Financial Analysis

13.20.3 Product Matrix

13.20.4 Recent Developments

13.20.5 Databridge Analysis

13.21 Paul Hartmann Limited

13.21.1 Company Overview

13.21.2 Financial Analysis

13.21.3 Product Matrix

13.21.4 Recent Developments

13.21.5 Databridge Analysis

13.22 Deroyal Industries Inc

13.22.1 Company Overview

13.22.2 Financial Analysis

13.22.3 Product Matrix

13.22.4 Recent Developments

13.22.5 Databridge Analysis

13.23 Paul Hartmann Limited

13.23.1 Company Overview

13.23.2 Financial Analysis

13.23.3 Product Matrix

13.23.4 Recent Developments

13.23.5 Databridge Analysis

13.24 Dermarite Industries Llc

13.24.1 Company Overview

13.24.2 Financial Analysis

13.24.3 Product Matrix

13.24.4 Recent Developments

13.24.5 Databridge Analysis

14 Appendix

15 About Data Bridge Market Research

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Acelity L.P. INC, Smith and Nephew, Molnlycke, Convatec INC.,3M,Baxter, Coloplast, Ethicon INC., Paul Hartmann Limited

Company Profile

Company Profile Title

In this region, Belgium advanced wound care market is projected to reach USD 28.0 million by 2024 from USD 22.6 million in 2016, at a CAGR of 2.8% in the forecast period 2017 to 2024. Netherlands advanced wound care market is projected to reach USD 167.9 million by 2024 from USD 135.4 million in 2016, at a CAGR of 2.8% in the forecast period 2017 to 2024.

Some of the major players operating in this market are

Acelity L.P. INC,

Smith and Nephew,

Molnlycke, Convatec INC.,

3M,

Baxter,

Coloplast,

Ethicon INC.,

Paul Hartmann Limited

The Belgium and Netherlands advance wound care market is segmented on the basis of type, wound type, end-user, distribution channel, and geography. The Belgium and Netherlands advance wound care market is segmented into three types, such as dressing, therapy devices and biologics

Dressing is further segmented into foam dressings, hydrogels, film dressings, alginates, wound contact layer, and super absorbent dressing. Also, biologics market is further segmented into synthetic skin grafts, growth factors, allografts, and xenografts.

The therapy devices are further segmented into negative pressure wound therapy, pressure relief devices (PRD), wound debridement devices, hyperbaric oxygen chambers, and physical therapies.

The growth factors are further divided into platelet-derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), Talactoferrin ALFA, thrombin peptide (TP508), and keratinocyte growth factor (KGF).

The negative pressure wound therapy (NPWT) is further classified into standalone NPWT devices, portable NPWT devices, and disposable NPWT devices. The pressure relief devices (PRD) are further classified into mattress and bed.

The hyperbaric oxygen chambers are further classified into monoplace, multiplace, and topical. The wound debridement devices are further classified into hydrosurgical, ultrasound, mechanical, and others. The physical therapies are further classified into laser therapy, electrical stimulation, external shock wave therapies (ESWT), and saline mist therapy.

On the basis of wound type, the Belgium and Netherlands advance wound care market is segmented into surgical wound, diabetic ulcers, burns, pressure ulcers, venous ulcers and others.

On the basis of end users, the Belgium and Netherlands advance wound care marketis segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics and community healthcare.

On the basis of distribution channel, the Belgium and Netherlands advance wound care marketis segmented into direct tenders and retailers.

READ MORE

Scope

Table Of Contents

1. Introduction

1.1 Overview Of The Belgium And Netherlands Advanced Wound Care Market

1.2 Currency And Pricing

1.3 Limitation

1.4 Markets Covered

2 Market Segmentation

2.1 Key Takeaways

2.2 Arriving At The Belgium And Netherlands Advanced Wound Care Market

2.2.1 Market Crackdown Approach

2.2.2 Company Revenue And Market Share Analysis

2.2.3 Data Triangulation

2.2.4 Key Data Points From Primary Sources

2.2.5 Key Data Points From Secondary Sources

2.2.6 Porter'S Five Forces Matrix

2.2.7 Pest Analysis

2.2.8 Epidemiology Forecasting Models

2.3 Belgium And Netherlands Advanced Wound Care Market:Research Snapshot

2.4 Assumptions

3 Market Overview

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

4 Executive Summary

5 Premium Insights

6 Belgium And Netherlands Advanced Wound Care Market, By Type

6.1 Overview

6.2 Dressings

6.3 Biologics

6.4 Therapy Devices

7 Belgium And Netherlands Advanced Wound Care Market, By Wound Type

7.1 Overview

7.2 Surgical Wounds

7.3 Diabetic Ulcers

7.4 Pressure Ulcers

7.5 Venous Ulcers

7.6 Burns

7.7 Other Traumatic Wounds

8 Belgium And Netherlands Advanced Wound Care Market, By End User

8.1 Overview

8.2 Hospitals

8.3 Wound Care Centers

8.4 Ambulatory Centers

8.5 Clinics

8.6 Community Healthcare

8.7 Home Healthcare

9 Belgium And Netherlands Advanced Wound Care Market, By Istribution Channel

9.1 Overview

9.2 Direct Tenders Public

9.3 Retail Private

10 Belgium And Netherlands Advanced Wound Care Market, By Country

10.1 Countrywise Belgium And Netherlands Advanced Wound Care Market, (All Segmentation Provided Above Is Represented In This Chapter By Country)

10.1.1 Belgium

10.1.2 Netherlands

10.2 Key Primary Insights: By Major Countries

11 Belgium Advanced Wound Care Market: Competitive Landscape

11.1. Belgium Advanced Wound Care Market: Company Share Analysis

11.2. Mergers & Acquisitions

11.3. New Product Development & Approvals

11.4. Expansions

11.5. Regulatory Changes

11.6. Partnership And Other Strategic Developments

12 Netherlands Advanced Wound Care Market: Competitive Landscape

12.1. Netherlands Advanced Wound Care Market: Company Share Analysis

12.2. Mergers & Acquisitions

12.3. New Product Development & Approvals

12.4. Expansions

12.5. Regulatory Changes

12.6. Partnership And Other Strategic Developments

13 Belgium And Netherlands Advanced Wound Care Market, Company Profiles

13.1 3M

13.1.1 Company Overview

13.1.2 Financial Analysis

13.1.3 Product Matrix

13.1.4 Recent Developments

13.1.5 Databridge Analysis

13.2 Smith And Nephew

13.2.1 Company Overview

13.2.2 Financial Analysis

13.2.3 Product Matrix

13.2.4 Recent Developments

13.2.5 Databridge Analysis

13.3 Medtronic

13.3.1 Company Overview

13.3.2 Financial Analysis

13.3.3 Product Matrix

13.3.4 Recent Developments

13.3.5 Databridge Analysis

13.4 Molnlycke Healthcare Ab

13.4.1 Company Overview

13.4.2 Financial Analysis

13.4.3 Product Matrix

13.4.4 Recent Developments

13.4.5 Databridge Analysis

13.5 Convatec Inc

13.5.1 Company Overview

13.5.2 Financial Analysis

13.5.3 Product Matrix

13.5.4 Recent Developments

13.5.5 Databridge Analysis

13.6 Baxter

13.6.1 Company Overview

13.6.2 Financial Analysis

13.6.3 Product Matrix

13.6.4 Recent Developments

13.6.5 Databridge Analysis

13.7 Coloplast

13.7.1 Company Overview

13.7.2 Financial Analysis

13.7.3 Product Matrix

13.7.4 Recent Developments

13.7.5 Databridge Analysis

13.8 Ethicon. Inc

13.8.1 Company Overview

13.8.2 Financial Analysis

13.8.3 Product Matrix

13.8.4 Recent Developments

13.8.5 Databridge Analysis

13.9 Integra Life Sciences Corporation

13.9.1 Company Overview

13.9.2 Financial Analysis

13.9.3 Product Matrix

13.9.4 Recent Developments

13.9.5 Databridge Analysis

13.10 Hollister Inc

13.10.1 Company Overview

13.10.2 Financial Analysis

13.10.3 Product Matrix

13.10.4 Recent Developments

13.10.5 Databridge Analysis

13.11 B. Braun Melsungen Ag

13.11.1 Company Overview

13.11.2 Financial Analysis

13.11.3 Product Matrix

13.11.4 Recent Developments

13.11.5 Databridge Analysis

13.12 Medline Industries

13.12.1 Company Overview

13.12.2 Financial Analysis

13.12.3 Product Matrix

13.12.4 Recent Developments

13.12.5 Databridge Analysis

13.13 Mimedx Group

13.13.1 Company Overview

13.13.2 Financial Analysis

13.13.3 Product Matrix

13.13.4 Recent Developments

13.13.5 Databridge Analysis

13.14 Organo Genesis Inc

13.14.1 Company Overview

13.14.2 Financial Analysis

13.14.3 Product Matrix

13.14.4 Recent Developments

13.14.5 Databridge Analysis

13.15 Talley Group Limited

13.15.1 Company Overview

13.15.2 Financial Analysis

13.15.3 Product Matrix

13.15.4 Recent Developments

13.15.5 Databridge Analysis

13.16 Bsn Medical

13.16.1 Company Overview

13.16.2 Financial Analysis

13.16.3 Product Matrix

13.16.4 Recent Developments

13.16.5 Databridge Analysis

13.17 Devon Medical Products

13.17.1 Company Overview

13.17.2 Financial Analysis

13.17.3 Product Matrix

13.17.4 Recent Developments

13.17.5 Databridge Analysis

13.18 Human Biosciences Inc

13.18.1 Company Overview

13.18.2 Financial Analysis

13.18.3 Product Matrix

13.18.4 Recent Developments

13.18.5 Databridge Analysis

13.19 Advancis Medical

13.19.1 Company Overview

13.19.2 Financial Analysis

13.19.3 Product Matrix

13.19.4 Recent Developments

13.19.5 Databridge Analysis

13.20 Cardinal Health

13.20.1 Company Overview

13.20.2 Financial Analysis

13.20.3 Product Matrix

13.20.4 Recent Developments

13.20.5 Databridge Analysis

13.21 Paul Hartmann Limited

13.21.1 Company Overview

13.21.2 Financial Analysis

13.21.3 Product Matrix

13.21.4 Recent Developments

13.21.5 Databridge Analysis

13.22 Deroyal Industries Inc

13.22.1 Company Overview

13.22.2 Financial Analysis

13.22.3 Product Matrix

13.22.4 Recent Developments

13.22.5 Databridge Analysis

13.23 Paul Hartmann Limited

13.23.1 Company Overview

13.23.2 Financial Analysis

13.23.3 Product Matrix

13.23.4 Recent Developments

13.23.5 Databridge Analysis

13.24 Dermarite Industries Llc

13.24.1 Company Overview

13.24.2 Financial Analysis

13.24.3 Product Matrix

13.24.4 Recent Developments

13.24.5 Databridge Analysis

14 Appendix

15 About Data Bridge Market Research

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Acelity L.P. INC, Smith and Nephew, Molnlycke, Convatec INC.,3M,Baxter, Coloplast, Ethicon INC., Paul Hartmann Limited